A new report from Cordavis, a CVS Healthspire company, outlined current challenges with the development and commercialization of biosimilars in the US, as well as how the organization is working to expand access and affordability of these products.Image credit: monticellllo – stock.adobe.comThe report was authored by Sree Chaguturu, MD, executive vice president and chief medical…
